Prime Medicine (PRME) Retained Earnings (2021 - 2025)
Prime Medicine (PRME) has disclosed Retained Earnings for 5 consecutive years, with $82000.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings rose 8100.0% year-over-year to $82000.0, compared with a TTM value of $82000.0 through Dec 2025, up 8100.0%, and an annual FY2025 reading of $82000.0, up 8100.0% over the prior year.
- Retained Earnings was $82000.0 for Q4 2025 at Prime Medicine, up from $33000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $82000.0 in Q4 2025 and bottomed at -$791.7 million in Q2 2025.
- Average Retained Earnings over 5 years is -$224.9 million, with a median of -$384000.0 recorded in 2022.
- Peak annual rise in Retained Earnings hit 8100.0% in 2025, while the deepest fall reached 777902.11% in 2025.
- Year by year, Retained Earnings stood at -$171.4 million in 2021, then surged by 99.78% to -$384000.0 in 2022, then plummeted by 127850.52% to -$491.3 million in 2023, then surged by 100.0% to $1000.0 in 2024, then soared by 8100.0% to $82000.0 in 2025.
- Business Quant data shows Retained Earnings for PRME at $82000.0 in Q4 2025, $33000.0 in Q3 2025, and -$791.7 million in Q2 2025.